Clozapine

Rehospitalization risk with second-generation and depot antipsychotics.

Conley RR, Kelly DL, Love RC, McMahon RP. Rehospitalization risk with second-generation and depot antipsychotics. Ann Clin Psychiatry. 2003;15(1):23-31. PubMed PMID: 12839430.

Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Fitton A, Benfield P. Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia. Pharmacoeconomics. 1993;4(2):131-56. PubMed PMID: 10146973.

Comments on the role of therapeutic drug monitoring for clozapine.

Preskorn SH. Comments on the role of therapeutic drug monitoring for clozapine. J Psychiatr Pract. 2005;11(5):340-3. PubMed PMID: 16184073.

Augmentation of Clozapine With ECT: Observations From India.

Grover S, Hazari N, Chakrabarti S, Avasthi A. Augmentation of Clozapine With ECT: Observations From India. Am J Psychiatry. 2015;172(5):487. DOI: 10.1176/appi.ajp.2014.14091170. PubMed PMID: 25930136.

Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine.

Rajji TK, Mulsant BH, Davies S, Kalache SM, Tsoutsoulas C, Pollock BG, et al. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine. Am J Psychiatry. 2015;172(6):579-85. DOI: 10.1176/appi.ajp.2015.14050673. PubMed PMID: 25859763.

Suicidal risk during treatment with clozapine: a meta-analysis.

Hennen J, Baldessarini RJ. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophrenia Res. 2005;73(2-3):139-45. DOI: 10.1016/j.schres.2004.05.015. PubMed PMID: 15653256.

Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine.

Spivak B, Roitman S, Vered Y, Mester R, Graff E, Talmon Y, et al. Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Clin Neuropharmacol. 1998;21(4):245-50. PubMed PMID: 9704166.

The InterSePT suicide scale for prediction of imminent suicidal behaviors.

Ayer DW, Jayathilake K, Meltzer HY. The InterSePT suicide scale for prediction of imminent suicidal behaviors. Psychiatry Res. 2008;161(1):87-96. DOI: 10.1016/j.psychres.2007.07.029. PubMed PMID: 18786729.

Clozapine use and outcomes among patients with treatment resistant schizophrenia.

El-Badri S, Mellsop G. Clozapine use and outcomes among patients with treatment resistant schizophrenia. Australas Psychiatry. 2011;19(5):410-4. DOI: 10.3109/10398562.2011.602078. PubMed PMID: 21864010.

Addressing nonresponse in schizophrenia.

Kane JM. Addressing nonresponse in schizophrenia. J Clin Psychiatry. 2012;73(2):e07. DOI: 10.4088/JCP.11076tx2c. PubMed PMID: 22401484.